by Ian Harvey
October 03, 2018
OUT WHILST THE GOING IS GOOD!
GREED CAN BE THE UNDOING OF A GOOD PROFIT!
Marijuana stocks Tilray and Canopy, on Monday, joined
stocks posting solid gains due to Canada joining the U.S. and Mexico in forging
a renewed regional trade agreement. On top of this continued volatility, Tilray
said that its High Park Farms subsidiary had received a license from health
regulator Health Canada to sell recreational cannabis, a key approval in
advance of the opening of the Canadian market in just over two weeks. These
factors helped to provide excellent potential profits of 217% for Tilray, and 58%
for Canopy options trades. More options trades are being considered…..read the
previous article “Marijuana Stock Winners
Canopy and Cronos Despite Volatility!”
In two weeks, on Oct. 17, Canada marks the official start of recreational marijuana sales in licensed dispensaries. Despite being a long time coming, the legalization of adult-use weed in Canada should yield billions of dollars in added annual sales for the industry, once it's fully ramped up.
Marijuana stock valuations have soared in the past few months as there has been an expected influx of demand, and that marijuana companies will be making a lot of money.
PATIENCE PAYS OFF!
YOU NEED TO BE IN TO PROFIT!
Moving Forward…..Stock Considerations….
Marijuana stock Tilray, which has only been a publicly traded company for about two and a half months after pricing its shares at $17, has soared. In September, shares of Tilray tripled in less than three days, hitting $300 a share on an intraday basis, and peaked at a valuation of $28 billion. In the days that followed its rapid ascension, Tilray would lose roughly two-thirds of its value, and the stock has remained volatile ever since.
So, for September, Tilray Inc.'s final stock price expansion was 122%.
By the end of 2018, Tilray expects to have more than 850,000 square feet of growing capacity, or enough to produce around 100,000 kilograms of cannabis annually.
Tilray already has supply agreements with seven provinces and territories, including Ontario, Quebec, and British Columbia. Tilray also has agreements with Novartis to collaborate on the sale of medical cannabis products, and supply agreements with pharmacy chains to supply medicinal use products.
On Monday shares of Tilray gained 15%. The Canadian cannabis manufacturer said that its High Park Farms subsidiary had received a license from health regulator Health Canada to sell recreational cannabis, a key approval in advance of the opening of the Canadian market in just over two weeks.
Canopy Growth Corp…..
Canopy Growth is noted as the top marijuana stock in terms of market cap. Canopy is in the best position of any Canadian marijuana grower to thrive over the long run.
One major reason that Canopy’s prospect look enticing is its association with the big alcoholic beverage company Constellation Brands. Constellation bought a 9.9% stake in Canopy last year. The Corona beer maker's recent $4 billion investment in Canopy totally changed the dynamics in the cannabis industry.
As a result of this massive investment, Canopy now has a huge cash stockpile that it plans to use to rapidly expand. Canopy co-CEO Bruce Linton stated that his company has a list of potential acquisition targets to cement its leadership position in the industry.
Canopy will continue to be a leader in this market, giving the stock plenty of room to run over the years to come.
FUTURE ACTION TO CONSIDER…..
Depending on the market today; wait and see the direction that the stocks are moving in before executing any suggested trades.
Yesterday saw cannabis stocks fall across the board after PepsiCo told investors that the food and beverage giant said it has no plans to invest in marijuana.
Tilray, one of the most volatile of the weed equities, lost about one-fifth of its value at one point. The shares closed lower by 16.25 percent. And after-hours saw the stock move another 4.05% lower to $132.58.
Canopy Growth dropped 7.4 percent.
1. ** A New Options Trade To Consider: Buy the TLRY DEC 21 2018 150.000 CALL at approximately$15.00 to $20.00. (Check the market before executing) Sell price is left to your own judgment.
2. ** A New Options Trade To Consider: Buy the CGC JAN 18 2019 50.000 CALL at approximately $6.00. Sell price is left to your own judgment.
SO PROFIT FROM OPTIONS TRADING!Strategies to Consider……
It is also worth considering, when options trading earnings reports – “Do we exit on already existing profits or leave the companies to report their earnings and hope for bigger profit?” .....READ MORE.....
"Trading Capital Management" is a key component of your trading strategy. The strategy, on which we base our trades to achieve maximum profit, and to minimize loss, is contingent on using an equal amount of money for each trade.……continue reading this article……
Our proven track record says it all!!
Members of Stock Options Made Easy are provided with an extensive reason as to which direction a stock will move after earnings, followed up by a recommended options trade.
If you not a member and interested in being part of this profitable action just CLICK HERE.
Other Membership Options…….
If you interested in "Earnings Predictions" just click here……
or "Mentorship Program".....click here....